ticular, the rates of resistance to nalidixic acid of S. Typhimurium strains from Hong Kong and China were 73% and 63%, respectively. The corresponding rates of resistance to ciprofloxacin (MIC м 2 mg/liter) were 34% and 36%, respectively ( Table 1) .
The mechanisms mediating the high prevalence of fluoroquinolone resistance in S. Typhimurium was investigated. We previously found that oqxAB, a plasmid-mediated resistance-nodulation-cell division (RND) efflux pump conferring resistance to multiple antibiotics, existed in Salmonella isolates recovered from food samples (8) . We then assessed the prevalence of oqxAB in human clinical S. Typhimurium isolates. It showed that the prevalence of oqxAB increased markedly in S. Typhimurium from 2005 to 2011. Among the Hong Kong isolates, the overall oqxABpositive rate was about 28% (67 out of 239 isolates), yet this resistance determinant was not detectable in salmonellae in 2005 and an increasing trend was observed only from 2006 onwards, with positivity rates of 12%, 24%, 34%, 34%, 37%, and 43% detectable among the S. Typhimurium isolates recovered in 2006 through Typhimurium strains in this study from Hong Kong (HK) and China (ICDC) were subjected to XbaI digestion and PFGE analysis. Ib-cr . No other PMQR genes were detected in these S. Typhimurium isolates. oqxAB was also found to be associated with multidrug resistance in S. Typhimurium. Among the S. Typhimurium isolates of the oqxAB-positive group, 94% and 98% from Hong Kong and the ICDC, respectively, were resistant to ciprofloxacin (MIC м 2 mg/liter), while the corresponding resistance rate in oqxAB-negative S. Typhimurium Hong Kong and ICDC isolates was only 11% (Table 1 ). In addition, the ACSSuT resistance type was detected in 58% and 53% of the oqxAB-positive S. Typhimurium isolates from Hong Kong and China, respectively, while the corresponding rate in oqxAB-negative S. Typhimurium was only around 10%.
The clonal relationships of oqxAB-positive salmonella isolates were examined by pulsed-field gel electrophoresis (PFGE) according to the PulseNet PFGE protocol for salmonella (9) . For the 159 oqxAB-positive ICDC isolates, 61 PFGE patterns were observed among the oqxAB-positive strains. Interestingly, the majority (37%) of oqxAB-positive isolates belonged to one PFGE type, designated CN0006 (Fig. 1) . For 67 oqxAB-positive Hong Kong isolates, 18 PFGE patterns were detectable among the oqxAB-positive isolates; again 57% of the oqxAB-positive strains belonged to the CN0006 type (Fig. 1) . Using an 80%-cutoff Dice coefficient index for the PFGE profiles, about 83% and 66% of S. Typhimurium isolates from Hong Kong and China, respectively, were related to the CN0006 clone. This finding suggested that CN0006 and related clones are responsible for the expansion of the ACSSuTciprofloxacin-oqxAB-aac(6=)Ib-cr type of S. Typhimurium in clinical settings in China. Multilocus sequence typing (MLST) was performed using primer sets as suggested at www.mlst.net. Results of MLST showed that all of the 20 randomly selected oqxAB-positive strains from Hong Kong and 16 out of the 20 randomly selected S. Typhimurium strains from the ICDC belonged to a specific sequence type, ST34, a sequence type that was frequently associated with the ACSSuT resistance type of S. Typhimurium, which is also frequently reported in the European Union (10) . The quick expansion of the multidrug-resistant S. Typhimurium ST34 clone will pose a notable threat to clinical Salmonella infection control. Urgent actions are required to halt its further transmission in both environmental and clinical settings.
